1/ #COVID19 is having a significant impact on prevalence of other common respiratory pathogens, like influenza.

Globally, since COVID began, influenza cases are down * 98% * (see tweet-link below).

The Canadian data and implications are explored here🧵

2/ Guess what

Here in Canada, flu cases also *collapsed* when #COVID19 arrived

Since mid-April to today, lab-confirmed flu cases in Canada are: 154

Average of same the time-period in previous flu seasons?

*3,836*

(…despite increased flu testing)
3/ Here is an interesting visual

The 19/20 flu season (interrupted by #COVID19) vs. avg of ’16-‘19 flu seasons. # of cases and positivity % by week.

In 19/20, flu cases/positivity dive to near ZERO, whilst previous years the decline is (i) gradual, and (ii) never reaches zero.
4/ It gets better

We are 7 wks into the 20/21 flu season

So far, there are *11* flu confirmed cases in Canada (vs. historical avg of 246)

They are all in Ontario

I repeat: there are no lab-confirmed cases of flu outside of Ontario this season
5/ Also…

According to FluWatch Canada data (bit.ly/3dKURr1)...

...there were 17 flu hospitalizations so far in last year’s flu season. This year ?

ZERO
6/ And we don’t even know which strains are circulating this year…

(this time last year we Canadian labs had already characterized 8 strains).
7/ What is happening with other respiratory viruses, such as RSV, parainfluenza, other coronaviruses, adenoviruses, etc.?

What are the positivity rates of those pathogens and the flu since #COVID19 arrived, compared to prior years?

Well…

Here you go:
8/ Same chart again:

We that observe in the 26 weeks since #COVID19 arrived, we are approaching MINISCULE positivity rates for these other common pathogens, with positivity rates down 90%+ across the board.

(testing/surveillance is higher for all pathogens)

Simply staggering.
9/ Why is this not being talked about more, especially by public health officials, and why aren't journalists digging into this data and asking questions?
10/ So what does this all mean?

First: there are interesting *potential* healthcare system implications…

Influenza hospitalizations are ~12,000/year in Canada (see citations below).
11/ So far, #COVID19 hospitalizations Canada-wide have been ~13,000.
12/ *IF* (and that is a big *IF*) influenza circulates at a lower level this year, we may have more hospital capacity than we expect to deal with a potential next wave of #COVID19.
13/ Other questions come to mind (for others who are actually qualified to answer):

(1) Why are health officials/scientists/media not talking more about this? (this data is all from Health Canada)
(2) Can these pathogens recirculate again at historical levels despite decimation?
14/

(3) Obvious questions arise regarding flu vaccine policy?
(4) Are there implications for the human immune system if these viruses no longer circulate widely?
(5) What caused such dramatic declines in other pathogen circulation? Lockdowns/improved hygiene?
15/ Continuing to follow influenza and other respiratory pathogen data will be important as we head into the late fall and winter, when infections typically pick up steam.

If they don’t, the questions become more relevant.

Thanks for reading. End.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kelly Brown

Kelly Brown Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @rubiconcapital_

23 Sep
1/ Spent the evening slicing and dicing the @ONThealth COVID19 case-by-case database. Found here: data.ontario.ca/en/dataset/con…
2/ My goal was to see if I could glean anything from the data that could answer why rising case numbers are not resulting in material increases in new hospitalizations, and why new deaths are de minimis. @ONThealth
3/ We are seeing this phenomenon in many jurisdictions around the world (case explosions, deaths flatlined). The UK is one very good example, and Canada is experiencing the same. ImageImage
Read 17 tweets
31 Aug
– Valuation Musings

In my view, XPEL has “earned the right” to be valued using a DCF.

Its moat is well-documented, and evidenced by the numbers; hyper revenue growth rates, expanding operating margins, and very high and growing software-like returns on invested capital. Image
Henceforth, will likely always look expensive on trailing numbers. But if its moat is sustainable, for a “good” number of years to come, then its powerful combination of high growth with high ROIC means the value resides way, way out there [into the future]. Image
The following tables summarize my DCF’s output for NPV/share under a [wide] range of potential future revenue/EBITDA growth scenarios, under various #’s of years prior to the point when a terminal value growth rate is then assumed (4.5% ‘r’ in all cases, 9% WACC). Image
Read 6 tweets
30 Jun


Initiated a position today @ $.075/sh

BASIC THESIS:

Now a [more 'investable'] "levered equity stub" after closing $24m equity fin'g @ $.13/sh, repaying almost all punative/vigilante debt, w/ highly manageable maturities, breakeven+, and runway to reveal earnings power. ImageImage
B/S is truly (and finally) significantly strengthened imo, w/ latest raise quite likely the last.

Mkt cap ~$50m & EV ~$175m, 71m warrants @.07/sh ($5m infusion), & 181m warrants @.16/sh ($30m infusion) would heal B/S even more, and could result in reflexive price recovery.
Interesting Friday filing on

MMCAP took 41% of the recent $0.13/unit 1-share/1-warrant bot deal (75m of 181m units/shares).

But, the filing disclosed only 75m warrants, and no associated shares (only legacy shares), potentially implying short sales before/after bot deal.
Read 7 tweets
1 Mar
/ - picks/shovels for IVF industry

CEO put on a 5yr clinic in measured value creation / capital allocation

Business building historically funded by shares/cash, but EBIT PER SHARE GREW. ROIC stable.

Now net cash, acquisitions can be funded w/balance sheet

Flywheel ImageImageImageImage
Impressively, from '16 to '20:

Tangible capital grew 328% from $1.5m to $7.5m, while returns on tang cap maintained at +100% [good underlying business]

AND

Total capital grew 297% from $9m to $36m, while returns on tot cap maintained at 20-25% [good cap allocation] Image
In vitro fertilization holding up well Image
Read 4 tweets
18 Jan
Let me tell you a story about how a nice family lost their farm to a bay st hedge fund.
It all started back in October 2018
Well let me tell you, at that time the greatest risk free piece of paper ever structured was structured.
Read 18 tweets
24 Nov 19
Thread: SG&A/g of major Canadian cannabis LPs

(then CoGS/g & Total Cost/g; illuminates which LPs structurally unprofitable @ inevitable $6-7/g retail)

1/ Highest SG&A LPs:

: ~$650m
: ~$350m

SG&A/g (assuming market share of 100,000 kgs each):

CGC: $6.40/g
ACB: $3.50/g
2/ Mid-tier SG&A LPs:

: ~$160m
: ~$140m
: ~$123m
: ~$123m

SG&A/g (assuming market share of 80,000 kgs each):

TLRY: $1.96/g
HEXO: $1.74/g
APHA: $1.54/g
CRON: $1.54/g
3/ Lowest SG&A of major LPs

: ~$44m
: ~$35m

SG&A/g (assuming market share of 60,000 kgs each):

ZENA: $0.73/g
OGI: $0.59/g
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!